Core Viewpoint - As of May 6, 2025, BluFan Medical (002382) closed at 5.13 yuan, reflecting a 1.58% increase, with a trading volume of 223,200 hands and a transaction value of 113 million yuan [1] Group 1: Financial Performance - BluFan Medical reported a main revenue of 1.478 billion yuan for Q1 2025, representing a year-on-year increase of 1.59% [2] - The net profit attributable to shareholders was 77.0223 million yuan, showing a significant year-on-year increase of 177.86% [2] - The company’s gross profit margin stood at 17.17%, while the net profit margin was 5.58% [2] Group 2: Market Position and Ratios - The total market capitalization of BluFan Medical is 5.167 billion yuan, ranking 53rd in the medical device industry [2] - The company has a price-to-earnings ratio (P/E) of 16.77, significantly lower than the industry average of 52.22, ranking 11th in the industry [2] - BluFan Medical's price-to-book ratio (P/B) is 0.64, the best in the industry, compared to the industry average of 3.09 [2] Group 3: Capital Flow Analysis - On May 6, 2025, the net outflow of main funds was 4.8817 million yuan, accounting for 4.31% of the total transaction value [1] - Retail investors experienced a net outflow of 31,800 yuan, representing 0.03% of the total transaction value [1] - Over the past five days, the stock has seen fluctuating capital flows, with notable inflows and outflows from both main and retail investors [1]
股票行情快报:蓝帆医疗(002382)5月6日主力资金净卖出488.17万元